Unbound MEDLINE

Alpha2-adrenergic receptors attenuate secretagogue-induced endocytosis and promote exocytosis of intestinal NHE2 and NHE3. The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] Journal article

 
TitleAlpha2-adrenergic receptors attenuate secretagogue-induced endocytosis and promote exocytosis of intestinal NHE2 and NHE3.
Author(s)Musch MW, Arvans DL, Paris H, Chang E 
InstitutionU Chicago.
SourceJ Pharmacol Exp Ther 2009 Jun 25.
AbstractAdrenergic agonists, through activation of intestinal epithelial alpha 2-adrenergic receptors (a2AR), inhibit electrolyte secretion and promote absorption. The mechanisms of action to promote basal Na(+) absorption and inhibit stimulated secretion are incompletely understood. The effects of alpha 2-agonists on Na(+) transport were studied in a cell line, Caco2-3B, derived from the Caco2 cell line engineered to permanently express human alpha2A-adrenergic receptors. Serosal, but not mucosal, addition of the a2AR agonist clonidine increased Caco2-3B apical (22)Na(+) uptake, an effect not seen in the Caco2 parent line that lacks a2AR expression. This effect was blocked by the a2AR antagonist yohimbine. Increased Na(+) uptake was paralleled by increased apical surface abundance of the sodium/hydrogen exchangers NHE2 and NHE3. No changes in total cell NHE2 and NHE3 expression were observed. Clonidine also inhibited both cAMP and Ca(++)-induced decreases in apical Na(+) uptake and apical membrane NHE2 and NHE3 endocytosis stimulated by these agents. A2AR actions were mediated via stimulation of phospholipase C and metabolism of arachidonic acid by an epoxygenase activity followed epidermal growth factor release and activation of the EGF receptor, resulting in phosphatidyl inositol-3-kinase and Akt stimulation. In summary, activation of intestinal epithelial a2AR significantly blocks the inhibition of apical Na(+) transporters by cAMP- and Ca(++)-mediated pathways and also directly increases apical sodium/hydrogen exchange activities. By both blocking electrolyte secretion and promoting absorption, alpha2-agonists could be potent anti-diarrheal agents that could directly counteract the actions of toxigenic pathogens and other secretatogues causing secretory diarrhea.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19556451
  
Advertise on this site.